Add Yahoo as a preferred source to see more of our stories on Google. Alzheimer’s research is advancing with new biomarkers and therapies, but funding cuts threaten progress in treatment development. ...

Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential to be superior to monoclonal antibodies and restore ...

A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering ...

Add Yahoo as a preferred source to see more of our stories on Google. The presence of beta amyloid and tau proteins are hallmark signs of Alzheimer’s. Amyloid can begin to accumulate in the spaces ...

Boosting a specific protein in the brain could help slow the progression of Alzheimer’s disease, a new study has found. The longstanding theory is that Alzheimer’s occurs when a protein called amyloid ...

A main theory behind the cause of Alzheimer’s disease is the build-up of the protein amyloid-beta in the brain. Researchers from the University of Cincinnati provide evidence suggesting it’s the ...

Microglial activation is a determining factor that allows amyloid-beta accumulation to drive reactive astrogliosis, amplifying inflammatory responses in the brain. This was the conclusion of a study ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. New research bolsters evidence that people with early signs of Alzheimer’s can take ...

Researchers are engineering a new class of miniature antibodies, called intrabodies, that can operate inside living cells to break down the toxic proteins behind Alzheimer’s disease and motor neurone ...

Alzheimer’s disease, or AD, is a terrible illness that is currently affecting 7.2 million adults in the United States. The Alzheimer’s Association predicts that without improved medical research and t ...

Alzheimer’s disease has become one of the most urgent health challenges of the century. In the United States alone, one in three people older than 85 is estimated to live with the condition. The ...